APA (7th ed.) Citation

AV, G., ME, P., CS, S., TM, S., R, K., RA, R., & LA, B. (2026). Use of High-dose Intravenous Immunoglobulin as Initial Therapy for Heparin-induced Thrombocytopenia in Patients With High Bleeding Risk. Journal of cardiothoracic and vascular anesthesia, 40(2), 660. https://doi.org/10.1053/j.jvca.2025.08.051

Chicago Style (17th ed.) Citation

AV, Grazioli, Plazak ME, Shen CS, Scalea TM, Kundi R, Riojas RA, and Belyayev LA. "Use of High-dose Intravenous Immunoglobulin as Initial Therapy for Heparin-induced Thrombocytopenia in Patients With High Bleeding Risk." Journal of Cardiothoracic and Vascular Anesthesia 40, no. 2 (2026): 660. https://doi.org/10.1053/j.jvca.2025.08.051.

MLA (9th ed.) Citation

AV, Grazioli, et al. "Use of High-dose Intravenous Immunoglobulin as Initial Therapy for Heparin-induced Thrombocytopenia in Patients With High Bleeding Risk." Journal of Cardiothoracic and Vascular Anesthesia, vol. 40, no. 2, 2026, p. 660, https://doi.org/10.1053/j.jvca.2025.08.051.